The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.

@article{Turner2018TheUD,
  title={The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.},
  author={Leigh Turner},
  journal={Perspectives in biology and medicine},
  year={2018},
  volume={61 1},
  pages={
          7-24
        }
}
Hundreds of businesses and clinics in the United States are engaged in direct-to-consumer marketing of unproven and unlicensed stem cell-based interventions. This essay provides an overview of this marketplace, examines advertising techniques companies use to draw clients and legitimate marketing claims, and summarizes the roles the Food and Drug Administration (FDA) and other agencies are supposed to play in regulating the direct-to-consumer marketplace for stem cell interventions. The essay… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 60 REFERENCES

Amid Lawsuit, San Diego Stem Cell Company Pushes Back on

  • 2016
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Rejuvenating Regenerative Medicine Regulation.

  • The New England journal of medicine
  • 2018
VIEW 1 EXCERPT

Warning Letter to John S

Food, Drug Administration
  • Arnone, Chairman/ Chief Executive Officer, American Cryostem Corporation, Jan. 3. https://www.fda. gov/ICECI/EnforcementActions/WarningLetters/ucm591225.htm.
  • 2018

An Experiment That Blinded Three Women Unearths the Murky World of Stem Cell Clinics.

P. Aldous
  • BuzzFeed News, March 21. https://www.buzzfeed.com/ peteraldhous/stem-cell-tragedy-in-florida?utm_term=.egv7mWD45#.pxY74PxDK
  • 2017
VIEW 3 EXCERPTS